|
[1]RYERSON AB, EHEMAN CR, ALTEKRUSE SF, et al.Annual report to the nation on the status of cancer, 1975-2012, featuring the increasing incidence of liver cancer[J].Cancer, 2016, 122 (9) :1312-1337.
|
|
[2]YU JJ, YAN WT, QUAN B, et al.Recommendations for EASLClinical Practice Guidelines:Management of hepatocellular carcinoma (2018) [J].J Clin Hepatol, 2018, 34 (6) :1183-1186. (in Chinese) 余炯杰, 严文韬, 权冰, 等.《2018年欧洲肝病学会临床实践指南:肝细胞癌的管理》推荐意见[J].临床肝胆病杂志, 2018, 34 (6) :1183-1186.
|
|
[3] Liver Failure and Artificial Liver Group, Chinese Society of Infectious Diseases, CMA;Severe Liver Disease and Artificial Liver Group, Chinese Society of Hepatology, CMA.Guideline for diagnosis and treatment of liver failure[J].Chin J Clin Infect Dis, 2012, 5 (6) :321-327. (in Chinese) 中华医学会感染病学分会肝衰竭与人工肝学组, 中华医学会肝病学分会重型肝病与人工肝学组.肝衰竭诊治指南 (2012年版) [J].中华临床感染病杂志, 2012, 5 (6) :321-327.
|
|
[4] Chinese Society of Hepatology and Chinese Society of Infectious Diseases, Chinese Medical Association.The guideline of prevention and treatment for chronic hepatitis B (2010 version) [J].J Clin Hepatol, 2011, 27 (1) :I-XVI. (in Chinese) 中华医学会肝病学分会, 中华医学会感染病学分会.慢性乙型肝炎防治指南 (2010年版) [J].临床肝胆病杂志, 2011, 27 (1) :I-XVI.
|
|
[5]CAO XT.Medical immunology[M].6th edition, Beijing:People's Health Publishing House, 2015. (in Chinese) 曹雪涛.医学免疫学[M].第六版, 北京:人民卫生出版社, 2015.
|
|
[6]VARIKUTI S, OGHUMU S, ELBAZ M, et al.STAT1 gene deficient mice develop accelerated breast cancer growth and metastasis which is reduced by IL-17 blockade[J].Oncoimmunology, 2017, 6 (11) :e1361088.
|
|
[7]GAO B.Cytokines, STATs and liver disease[J].Cellular Mol Immunol, 2005, 2 (2) :92-100.
|
|
[8]NAJJAR I, FAGARD R.STAT1 and pathogens, not a friendly relationship[J].Biochimie, 2010, 92 (5) :425-444.
|
|
[9]KIM HS, LEE MS.STAT1 as a key modulator of cell death[J].Cell Signal, 2007, 19 (3) :454-465.
|
|
[10]WANG Y, YU X, SONG H, et al.The STAT-ROS cycle extends IFN-induced cancer cell apoptosis[J].Int J Oncol, 2018, 52 (1) :305-313.
|
|
[11]ZHANG Y, LIU Z.STAT1 in cancer:Friend or Foe?[J].Discov Med, 2017, 24 (130) :19-29.
|
|
[12]CHAN SR, VERMI W, LUO JQ, et al.STAT1-deficient mice spontaneously develop estrogen receptor a-positive luminal mammary carcinomas[J].Breast Cancer Res, 2012, 14:r16.
|
|
[13]LESINSKI GB, ANGHELINA M, ZIMMERER J, et al.The antitumor effects of IFN-αare abrogated in a STAT1-deficient mouse[J].J Clin Invest, 2003, 112 (2) :170-180.
|
|
[14]NAGAI H, NAKA T, TERADA Y, et al.Hypermethylation associated with inactivation of the SOCS-1 gene, a JAK/STAT inhibitor, in human hepatoblastomas[J].J Hum Genet, 2003, 48 (2) :65-69.
|
|
[15]CHIM CS, FUNG TK, CHEUNG WC, et al.SOCS1 and SHP1 hypermethylation in multiple myeloma:Implications for epigenetic activation of the Jak/STAT pathway[J].Blood, 2004, 103 (12) :4630-4635.
|
|
[16]COCHET O, FRELIN C, PEYRON JF, et al.Constitutive activation of STAT proteins in the HDLM-2 and L540 Hodgkin lymphoma-derived cell lines supports cell survival[J].Cell Signal, 2006, 18 (4) :449-455.
|
|
[17]GALM O, YOSHIKAWA H, ESTELLER M, et al.SOCS-1, a negative regulator of cytokine signaling, is frequently silenced by methylation in multiple myeloma[J].Blood, 2003, 101 (7) :2784-2788.
|
|
[18]TO KF, CHAN MW, LEUNG WK, et al.Constitutional activation of IL-6-mediated JAK/STAT pathway through hypermethylation of SOCS-1 in human gastric cancer cell line[J].Br J Cancer, 2004, 91 (7) :1335-1341.
|
|
[19]YOSHIKAWA H, MATSUBARA K, QIAN GS, et al.SOCS-1, a negative regulator of the JAK/STAT pathway, is silenced by methylation in human hepatocellular carcinoma and shows growth-suppression activity[J].Nat Genet, 2001, 28 (1) :29-35.
|
|
[20]CHUNG SS, WU Y, OKOBI Q, et al.Proinflammatory cytokines IL-6 and TNF-αincreased telomerase activity through NF-κB/STAT1/STAT3 activation, and withaferin a inhibited the signaling in colorectal cancer cells[J].Mediators Inflamm, 2017, 2017:5958429.
|
|
[21]AKRAM M, KIM KA, KIM ES, et al.Selective inhibition of JAK2/STAT1 signaling and i NOS expression mediates the anti-inflammatory effects of coniferyl aldehyde[J].Chem Biol Interact, 2016, 256:102-110.
|
|
[22]KAUR T, MUKHERJEA D, SHEEHAN K, et al.Short interfering RNA against STAT1 attenuates cisplatin-induced ototoxicity in the rat by suppressing inflammation[J].Cell Death Dis, 2011, 2:e180.
|
|
[23]SAMARDZIC T, JANKOVIC V, STOSIC-GRUJICIC S, et al.STAT1 is required for i NOS activation, but not IL-6 production in murine fibroblasts[J].Cytokine, 2001, 13 (3) :179-182.
|
|
[24]CAI JJ, GUO XL.Studies on telomerase reverse transcriptase components and liver cancer[J].Chin J Hepatol, 2016, 24 (7) :555-560. (in Chinese) 蔡嘉镜, 郭晓兰.端粒酶逆转录酶组分与肝癌研究[J].中华肝脏病杂志, 2016, 24 (7) :555-560.
|
|
[25]KO E, SEO HW, JUNG G.Telomere length and reactive oxygen species levels are positively associated with a high risk of mortality and recurrence in hepatocellular carcinoma[J].Hepatology, 2018, 67 (4) :1378-1391.
|
|
[26]YAN J, ZHOU Y, CHEN DX, et al.Effects of mitochondrial translocation of telomerase on drug resistance in hepatocellular carcinoma cells[J].J Cancer, 2015, 6 (2) :151-159.
|
|
[27]LI TF, SU CY, HUANG G, et al.IL-6 suppresses CCR7 expression in human monocyte-derived dendritic cells via STAT3 pathway[J].J Third Mil Med Univ, 2015, 37 (8) :751-756. (in Chinese) 李腾飞, 苏崇宇, 黄刚, 等, STAT3信号通路在IL-6抑制人单核细胞来源树突状细胞CCR7表达中的作用[J].第三军医大学学报, 2015, 37 (8) :751-756.
|
|
[28]XIONG QS, WU SS, WANG JW, et al.Hepatitis B virus promotes cancer cell migration by downregulating miR-340-5p expression to induce STAT3 overexpression[J].Cell Biosci, 2017, 7:16.
|
|
[29]WANG B, LIU T, WU JC, et al.STAT3 aggravates TGF-β1-induced hepatic epithelial-to-mesenchymal transition and migration[J].Biomed Pharmacother, 2018, 98:214-221.
|
|
[30]SHEN WX, CHEN CH, GUAN YY, et al.A pumpkin polysaccharide induces apoptosis by inhibiting the JAK2/STAT3 pathway in human hepatoma Hep G2 cells[J].Int J Biol Macromol, 2017, 104 (Pt A) :681-686.
|
|
[31]KIM HY, JHUN JY, CHO ML, et al.Interleukin-6 upregulates Th17 response via m TOR/STAT3 pathway in acute-on-chronic hepatitis B liver failure[J].J Gastroenterol, 2014, 49 (8) :1264-1273.
|
|
[32]KLEIN C, WVSTEFELD T, HEINRICH PC, et al.ME3738 protects from concanavalin A-induced liver failure via an IL-6-dependent mechanism[J].Eur J Immunol, 2003, 33 (8) :2251-2261.
|
|
[33]KIM SJ, CHO HI, KIM SJ, et al.Protective effect of linarin against D-galactosamine and lipopolysaccharide-induced fulminant hepatic failure[J].Eur J Pharmacol, 2014, 738 (10) :66-73.
|
|
[34]YANG NB, NI SL, LI SS, et al.Endotoxin tolerance alleviates experimental acute liver failure via inhibition of high mobility group box 1[J].Int J Clin Exp Pathol, 2015, 8 (8) :9062-9071.
|
|
[35]HO CH, FAN CK, YU HJ, et al.Testosterone suppresses uropathogenic Escherichia coli invasion and colonization within prostate cells and inhibits inflammatory responses through JAK/STAT-1 signaling pathway[J].PLo S One, 2017, 12 (6) :e0180244.
|
|
[36]WU XX, SUN Y, GUO WJ, et al.Rebuilding the balance of STAT1and STAT3 signalings by fusaruside, a cerebroside compound, for the treatment of T-cell-mediated fulminant hepatitis in mice[J].Biochem Pharmacol, 2012, 84 (9) :1164-1173.
|
DownLoad: